Stock listing

Shanghai:600079 Humanwell Healthcare (Group) Co.,Ltd. (ST人福) 股价

Follow Humanwell Healthcare (Group) Co.,Ltd. into a list and get an email when it puts out news.

Share price · SSE:600079

¥19.92 CNY +0.23 (+1.2%)

Close on Oct 14, 2026

Humanwell Healthcare (Group) Co.,Ltd. logo
Ticker
Shanghai:600079
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Shanghai
Currency
CNY

What changed lately

Latest news

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Obtaining the Marketing Authorization for Sugammadex Sodium Injection from the UK Medicines and Healthcare Products Regulatory Agency (MHRA)

Oct 14, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Obtaining the US FDA Approval Number for Diltiazem Hydrochloride Tablets

Oct 9, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Indicative Announcement on Disclosure of Proposal for 2026 Private Placement of A-Shares (Second Revised Draft)

Sep 30, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on the Dilution of Immediate Returns, Measures to Mitigate Such Dilution and the Undertakings by Relevant Parties in Relation to the Private Placement of A-Shares (Second Revised Draft)

Sep 30, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Signing Supplemental Agreement (II) to the Conditional Share Subscription Agreement for the Private Placement of Shares with the Controlling Shareholder and Related Party Transaction

Sep 30, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Resolutions of the 12th Meeting of the 11th Board of Directors

Sep 30, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Adjustments to the Plan for Private Placement of Shares

Sep 30, 2026

Announcement on Explanation of Revisions to Proposal for 2026 Private Placement of A-Shares (Second Revised Draft) and Relevant Documents

Sep 30, 2026

Indicative Announcement on the Reply to the Review Inquiry Letter Regarding the Application Documents for the Private Placement of Shares and Updates of the Prospectus and Other Application Documents

Sep 24, 2026

Announcement on Obtaining Drug Registration Certificate for Phloroglucinol Orally Disintegrating Tablets

Sep 12, 2026

All Humanwell Healthcare (Group) Co.,Ltd. news

Financings

  • Private placement of a-shares

    Sep 30, 2026 · US$499.45M

    Terms changed: CNY 3.35B

    Insiders: Shares are to be subscribed by the controlling shareholder under a conditional share subscription agreement; treated as a related party transaction

    Use of proceeds: Innovative drug R&D, a health and complex formulations manufacturing base, digital and intelligent upgrades, and working capital

    Update Sep 24, 2026 · Terms changed Sep 30, 2026 · Update Sep 30, 2026

Read by 6ix AI from the company's releases

Humanwell Healthcare (Group) Co.,Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
63 in the last 12 months · 79 in all · newest Oct 14, 2026 · oldest 2015

Log in to ask 6ix AI your own questions about Humanwell Healthcare (Group) Co.,Ltd.